Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical latanoprost combined with microneedling for alopecia areata
IRCT20220316054304N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Sep 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of latanoprost in alopecia areata, sponsored by Shiraz University of Medical Sciences. Started Sep 2022; status: completed.
02
Drugs
latanoprost
03
Conditions
alopecia areata
Beyond the preview
Go deeper on IRCT20220316054304N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220316054304N1.